Showing results (71-80 of 141) with videos related to
Sort By:
Pageof 15
British Journal of Pharmacology|July 16, 2015
The expanding role of immunopharmacology: IUPHAR Review 16Ekaterini Tiligada, Masaru Ishii, Carlo Riccardi, et al.The American Journal of Gastroenterology|April 30, 2021
Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc AnalysisKonstantinos Papamichael, Niels Vande Casteele, Jenny Jeyarajah, et al.World Journal of Gastrointestinal Endoscopy|June 26, 2019
Has the time been reached for pseudopolyps to be re-enrolled in endoscopic inflammatory bowel disease scores?Dimitrios S Politis, Konstantinos H Katsanos, Konstantinos Papamichael, et al.Scandinavian Journal of Gastroenterology|July 4, 2015
The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapyGerassimos J Mantzaris, Dimitrios Tsironikos, Xanthipi Tzanetakou, et al.Metabolism: Clinical and Experimental|July 30, 2010
Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitoninHelen Karga, Irene Giagourta, Garyphallia Papaioannou, et al.Journal of Crohn'S & Colitis|September 25, 2019
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-ResponseMiles P Sparrow, Konstantinos Papamichael, Mark G Ward, et al.Inflammatory Bowel Diseases|September 16, 2014
Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponseKonstantinos Papamichael, Ann Gils, Paul Rutgeerts, et al.Inflammatory Bowel Diseases|December 23, 2017
A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel DiseaseLaurie B Grossberg, Konstantinos Papamichael, Joseph D Feuerstein, et al.Journal of Crohn'S & Colitis|July 13, 2016
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative ColitisKonstantinos Papamichael, Filip Baert, Sophie Tops, et al.Clinical Therapeutics|April 20, 2016
Efficacy and Safety Profile of Anti-tumor Necrosis Factor-α Versus Anti-integrin Agents for the Treatment of Crohn's Disease: A Network Meta-analysis of Indirect ComparisonsMichael Miligkos, Konstantinos Papamichael, Niels Vande Casteele, et al.Pageof 15